These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 15817471)
1. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471 [TBL] [Abstract][Full Text] [Related]
2. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141 [TBL] [Abstract][Full Text] [Related]
3. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015 [TBL] [Abstract][Full Text] [Related]
4. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling. Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259 [TBL] [Abstract][Full Text] [Related]
5. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411 [TBL] [Abstract][Full Text] [Related]
6. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. Suzuki C; Murakami G; Fukuchi M; Shimanuki T; Shikauchi Y; Imamura T; Miyazono K J Biol Chem; 2002 Oct; 277(42):39919-25. PubMed ID: 12151385 [TBL] [Abstract][Full Text] [Related]
7. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251 [TBL] [Abstract][Full Text] [Related]
8. Differential ubiquitination defines the functional status of the tumor suppressor Smad4. Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Xu J; Attisano L Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087 [TBL] [Abstract][Full Text] [Related]
11. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. Lin X; Liang M; Feng XH J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919 [TBL] [Abstract][Full Text] [Related]
12. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. Shen R; Chen M; Wang YJ; Kaneki H; Xing L; O'keefe RJ; Chen D J Biol Chem; 2006 Feb; 281(6):3569-76. PubMed ID: 16299379 [TBL] [Abstract][Full Text] [Related]
13. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism. Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939 [TBL] [Abstract][Full Text] [Related]
14. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Kavsak P; Rasmussen RK; Causing CG; Bonni S; Zhu H; Thomsen GH; Wrana JL Mol Cell; 2000 Dec; 6(6):1365-75. PubMed ID: 11163210 [TBL] [Abstract][Full Text] [Related]
15. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis. Sangadala S; Metpally RP; Reddy BV J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934 [TBL] [Abstract][Full Text] [Related]
16. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. Lee PS; Chang C; Liu D; Derynck R J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389 [TBL] [Abstract][Full Text] [Related]
17. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. Ying SX; Hussain ZJ; Zhang YE J Biol Chem; 2003 Oct; 278(40):39029-36. PubMed ID: 12871975 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF-β Pathways. Aragón E; Goerner N; Xi Q; Gomes T; Gao S; Massagué J; Macias MJ Structure; 2012 Oct; 20(10):1726-36. PubMed ID: 22921829 [TBL] [Abstract][Full Text] [Related]
20. Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins. Nakano A; Koinuma D; Miyazawa K; Uchida T; Saitoh M; Kawabata M; Hanai J; Akiyama H; Abe M; Miyazono K; Matsumoto T; Imamura T J Biol Chem; 2009 Mar; 284(10):6109-15. PubMed ID: 19122240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]